Performing Laparoscopic Surgery for Colorectal and Gastric Cancer Outside the Primary Registered Medical Institution

NCT ID: NCT04834661

Last Updated: 2022-04-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1130 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-10-20

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study investigates the safety and feasibility of performing laparoscopic surgery for colorectal and gastric cancer inside versus outside the primary registered medical institution under multi-sites practice (MSP) policy. This is a single practitioner, retrospective comparative study. The endpoints are peri-operative outcomes, pathological results, and medical costs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Cancer Gastric Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

inside group

laparoscopic surgery for colorectal and gastric cancer inside the primary registered medical institution

surgery inside the primary institution

Intervention Type OTHER

to perform laparoscopic surgery for colorectal and gastric cancer inside the primary registered medical institution

outside group

laparoscopic surgery for colorectal and gastric cancer outside the primary registered medical institution

surgery outside the primary institution

Intervention Type OTHER

to perform laparoscopic surgery for colorectal and gastric cancer outside the primary registered medical institution

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

surgery inside the primary institution

to perform laparoscopic surgery for colorectal and gastric cancer inside the primary registered medical institution

Intervention Type OTHER

surgery outside the primary institution

to perform laparoscopic surgery for colorectal and gastric cancer outside the primary registered medical institution

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 18 and 100 years
* diagnosed as colorectal cancer or gastric cancer
* undergoing laparoscopic surgery between 2016-2020 performed by Dr Feng

Exclusion Criteria

* Emergency procedure
* without histopathological result of malignancy
* conventional open surgery
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai Minimally Invasive Surgery Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Cai Zhenghao

Attending surgeon of gastrointestinal surgery,Ruijin Hospital, Shanghai Jiaotong University School of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zhenghao Cai, MD

Role: PRINCIPAL_INVESTIGATOR

Ruijin Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ruijin Hospital

Shanghai, Shanghai Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

multi-sites practice surgery

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.